Cognitive dysfunction is relatively less considered a complication of hypertension. However, there is sufficient evidence to show that high blood pressure in middle age increases the risk of cognitive decline and dementia in old age. The greatest impact on cognitive function in those with hypertension is on executive or frontal lobe function, similar to the area most damaged in vascular dementia. Possible cognitive disorders associated with hypertension are vascular dementia, Alzheimer disease, and Lewy body dementia, listed in decreasing strength of association. The pathophysiology of cognitive dysfunction in individuals with hypertension includes brain atrophy, microinfarcts, microbleeds, neuronal loss, white matter lesions, network disruption, neurovascular unit damage, reduced cerebral blood flow, blood-brain barrier damage, enlarged perivascular damage, and proteinopathy. Antihypertensive drugs may reduce the risk of cognitive decline and dementia. Given the high prevalence of dementia and its impact on quality of life, treatment of hypertension to reduce cognitive decline may be a clinically relevant intervention.
Citations
Citations to this article as recorded by
Chronic Neuroinflammation and Cognitive Decline in Patients with Cardiac Disease: Evidence, Relevance, and Therapeutic Implications Jan Traub, Anna Frey, Stefan Störk Life.2023; 13(2): 329. CrossRef
The A-to-Z factors associated with cognitive impairment. Results of the DeCo study María Gil-Peinado, Mónica Alacreu, Hernán Ramos, José Sendra-Lillo, Cristina García, Gemma García-Lluch, Teresa Lopez de Coca, Marta Sala, Lucrecia Moreno Frontiers in Psychology.2023;[Epub] CrossRef
Some patients with type 1 and type 2 diabetes mellitus (DM) present with cognitive dysfunctions. The pathophysiology underlying this complication is not well understood. Type 1 DM has been associated with a decrease in the speed of information processing, psychomotor efficiency, attention, mental flexibility, and visual perception. Longitudinal epidemiological studies of type 1 DM have indicated that chronic hyperglycemia and microvascular disease, rather than repeated severe hypoglycemia, are associated with the pathogenesis of DM-related cognitive dysfunction. However, severe hypoglycemic episodes may contribute to cognitive dysfunction in high-risk patients with DM. Type 2 DM has been associated with memory deficits, decreased psychomotor speed, and reduced frontal lobe/executive function. In type 2 DM, chronic hyperglycemia, long duration of DM, presence of vascular risk factors (e.g., hypertension and obesity), and microvascular and macrovascular complications are associated with the increased risk of developing cognitive dysfunction. The pathophysiology of cognitive dysfunction in individuals with DM include the following: (1) role of hyperglycemia, (2) role of vascular disease, (3) role of hypoglycemia, and (4) role of insulin resistance and amyloid. Recently, some investigators have proposed that type 3 DM is correlated to sporadic Alzheimer’s disease. The molecular and biochemical consequences of insulin and insulin-like growth factor resistance in the brain compromise neuronal survival, energy production, gene expression, plasticity, and white matter integrity. If patients claim that their performance is worsening or if they ask about the effects of DM on functioning, screening and assessment are recommended.
Citations
Citations to this article as recorded by
Diabetic Encephalopathy: Role of Oxidative and Nitrosative Factors in Type 2 Diabetes Debashree Mazumdar, Santosh Singh Indian Journal of Clinical Biochemistry.2024; 39(1): 3. CrossRef
Nephroprotective properties of Achillea millefolium green-formulated Au NPs in streptozotocin-induced diabetic nephropathy in mice: Introducing a novel therapeutic drug for the treatment of nephropathy Nana Li, Xiu Wang, Shanshan Kong Inorganic Chemistry Communications.2024; 161: 112103. CrossRef
Changes in selected hematological parameters in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis Getachew Mesfin Bambo, Daniel Asmelash, Ermiyas Alemayehu, Alemu Gedefie, Tadesse Duguma, Samuel Sahile Kebede Frontiers in Medicine.2024;[Epub] CrossRef
A new nomogram model for the individualized prediction of mild cognitive impairment in elderly patients with type 2 diabetes mellitus Yuanyuan Jiang, Xueyan Liu, Huiying Gao, Jingzheng Yan, Yingjuan Cao Frontiers in Endocrinology.2024;[Epub] CrossRef
Sex Differences in the Trajectories of Cognitive Decline and Affected Cognitive Domains Among Older Adults With Controlled and Uncontrolled Glycemia Natália Cochar-Soares, Dayane C de Oliveira, Mariane M Luiz, Márlon J R Aliberti, Claudia K Suemoto, Andrew Steptoe, Cesar de Oliveira, Tiago S Alexandre, Jay Magaziner The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.2024;[Epub] CrossRef
The PI3K/Akt signaling axis and type 2 diabetes mellitus (T2DM): From mechanistic insights into possible therapeutic targets Rana Taheri, Yazdan Mokhtari, Amir‐Mohammad Yousefi, Davood Bashash Cell Biology International.2024; 48(8): 1049. CrossRef
The Role of Insulin Deficiency in Cognitive Dysfunction in Patients with Type 1 Diabetes Mellitus Yu. V. Bykov Fundamental and Clinical Medicine.2024; 9(2): 94. CrossRef
Prevalence of Candida albicans Infection Among Diabetic Foot Ulcer Patients in Al-Yarmouk Teaching Hospital Fatin Ali Al-Chalabi, Rabab Majead Abed, Mohsen Hashim Risan, Younus Desher Jabr Medical Journal of Babylon.2024; 21(Suppl 1): S137. CrossRef
Daphnetin modulates GLP-1R to alleviate cognitive dysfunction in diabetes: implications for inflammation and oxidative stress Feng Liang, Xinyi Tian, Lining Ding Frontiers in Pharmacology.2024;[Epub] CrossRef
Metformin Prevents NDEA-Induced Memory Impairments Associated with Attenuating Beta-Amyloid, Tumor Necrosis Factor-Alpha, and Interleukin-6 Levels in the Hippocampus of Rats Teresa Ponce-Lopez, José Antonio González Álvarez Tostado, Fernando Dias, Keren Happuck Montiel Maltez Biomolecules.2023; 13(9): 1289. CrossRef
Quercetin: an effective polyphenol in alleviating diabetes and diabetic complications Lei Yan, Mostafa Vaghari-Tabari, Faezeh Malakoti, Soheila Moein, Durdi Qujeq, Bahman Yousefi, Zatollah Asemi Critical Reviews in Food Science and Nutrition.2023; 63(28): 9163. CrossRef
Hyperglycemic microenvironment compromises the homeostasis of communication between the bone-brain axis by the epigenetic repression of the osteocalcin receptor, Gpr158 in the hippocampus Ericka Patricia da Silva, Geórgia da Silva Feltran, Sérgio Alexandre Alcântara dos Santos, Rodrigo Cardoso de Oliveira, Rahyza I.F. Assis, Luis Antônio Justulin Junior, Denise Carleto Andia, Willian F. Zambuzzi, Alexandra Latini, Rodrigo A. Foganholi da S Brain Research.2023; 1803: 148234. CrossRef
Research Progress on Lipocalin-2 in Diabetic Encephalopathy Wenjie Zhang, Shihong Chen, Xianghua Zhuang Neuroscience.2023; 515: 74. CrossRef
The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins Clement G. Yedjou, Jameka Grigsby, Ariane Mbemi, Daryllynn Nelson, Bryan Mildort, Lekan Latinwo, Paul B. Tchounwou International Journal of Molecular Sciences.2023; 24(10): 9085. CrossRef
Gender differences in cognitive function and its associated factors among older adults with type 2 diabetes Hua-Fen Chen, Ju Ying Jiang, Mei-Hsiu Chen, Rong Lin, Seng Wei Ooi Jerence, Chin-Huan Chang, Cheng-Chen Chou Geriatric Nursing.2023; 52: 165. CrossRef
Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review Mahima Koshatwar, Sourya Acharya, Roshan Prasad, Tejaswee Lohakare, Mayur Wanjari, Avinash B Taksande Cureus.2023;[Epub] CrossRef
Isolation and characterization of bacteria from diabetic foot ulcer: amputation, antibiotic resistance and mortality rate Muamar M. A. Shaheen, Sewar Al Dahab, Maryiam Abu Fada, Rawand Idieis International Journal of Diabetes in Developing Countries.2022; 42(3): 529. CrossRef
Genetic mutations of APOEε4 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer's disease Komal Jabeen, Kanwal Rehman, Muhammad Sajid Hamid Akash Journal of Biochemical and Molecular Toxicology.2022;[Epub] CrossRef
Aqueous Ajwa dates seeds extract improves memory impairment in type-2 diabetes mellitus rats by reducing blood glucose levels and enhancing brain cholinergic transmission Vasudevan Mani, Minhajul Arfeen, Sultan Sajid, Yasser Almogbel Saudi Journal of Biological Sciences.2022; 29(4): 2738. CrossRef
Diabetes Mellitus-Related Neurobehavioral Deficits in Mice Are Associated With Oligodendrocyte Precursor Cell Dysfunction Li-Ping Wang, Jieli Geng, Chang Liu, Yuyang Wang, Zhijun Zhang, Guo-Yuan Yang Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Single-Cell Sequencing Analysis of the db/db Mouse Hippocampus Reveals Cell-Type-Specific Insights Into the Pathobiology of Diabetes-Associated Cognitive Dysfunction Shizhan Ma, Wenkai Bi, Xueying Liu, Shangbin Li, Yaxin Qiu, Chengcheng Huang, Renjun Lv, Qingqing Yin Frontiers in Endocrinology.2022;[Epub] CrossRef
Impact of time in range during hospitalization on clinical outcomes in diabetic patients with toe amputation: a propensity score matching analysis Su Li, Ze-Xin Huang, Dong-hao Lou, Ye-Yong Jiang, Sheng Zhao BMC Surgery.2022;[Epub] CrossRef
Aberrant brain functional networks in type 2 diabetes mellitus: A graph theoretical and support-vector machine approach Lin Lin, Jindi Zhang, Yutong Liu, Xinyu Hao, Jing Shen, Yang Yu, Huashuai Xu, Fengyu Cong, Huanjie Li, Jianlin Wu Frontiers in Human Neuroscience.2022;[Epub] CrossRef
Does diabetes affect the risk of involvement in a motor vehicle crash? Jamie Dow, Lucie Boucher, David Carr, Judith L. Charlton, Linda Hill, Sjaan Koppel, Roy Lilley, Richard Marotolli, Desmond O'Neill, Mark Rapoport, Christine Roy, Neil Swirsky, Vincent Woo, Emmanuelle Gagné, Claude Giroux, Tamara Rader Journal of Transport & Health.2022; 27: 101509. CrossRef
No Effects of Acute Psychosocial Stress on Working Memory in Older People With Type 2 Diabetes Lorena Vallejo, Mariola Zapater-Fajarí, Teresa Montoliu, Sara Puig-Perez, Juan Nacher, Vanesa Hidalgo, Alicia Salvador Frontiers in Psychology.2021;[Epub] CrossRef
Neurovascular coupling alterations in type 2 diabetes: a 5-year longitudinal MRI study Yang Zhang, Xiaolu Zhang, Guangyang Ma, Wen Qin, Jiayang Yang, Jiahui Lin, Quan Zhang BMJ Open Diabetes Research & Care.2021; 9(1): e001433. CrossRef
Ameliorative effects of endurance training and Matricaria chamomilla flowers hydroethanolic extract on cognitive deficit in type 2 diabetes rats Ali Heidarianpour, Fereshteh Mohammadi, Maryam Keshvari, Naser Mirazi Biomedicine & Pharmacotherapy.2021; 135: 111230. CrossRef
The Link Between Nutrition and Alzheimer’s Disease: From Prevention to Treatment Laís Bhering Martins, Ana Letícia Malheiros Silveira, Antonio Lúcio Teixeira Neurodegenerative Disease Management.2021; 11(2): 155. CrossRef
Peripheral Polyneuropathy and Cognitive Impairment in Type II Diabetes Mellitus Rasha Elbialy Elsharkawy, Ghada Saed Abdel Azim, Marwa Abdellah Osman, Hend Maghraby Maghraby, Rehab Abdelfattah Mohamed, Eman Mahmoud Abdelsalam, Eman Elshohat Ebrahem, Nora Mohamed Ahmed Seliem Neuropsychiatric Disease and Treatment.2021; Volume 17: 627. CrossRef
SLC40A1 Mediates Ferroptosis and Cognitive Dysfunction in Type 1 Diabetes Lijun Hao, Jun Mi, Liping Song, Yinnan Guo, Yanli Li, Yiru Yin, Ce Zhang Neuroscience.2021; 463: 216. CrossRef
Relationship between peripheral neuropathy and cognitive performance in the elderly population Yu-Jen Lin, Tung-Wei Kao, Wei-Liang Chen Medicine.2021; 100(20): e26071. CrossRef
The Association Between Diabetes Mellitus and Mild Behavioral Impairment Among Mild Cognitive Impairment: Findings from Singapore See Ann Soo, Kok Pin Ng, Fennie Wong, Seyed Ehsan Saffari, Chathuri Yatawara, Zahinoor Ismail, Nagaendran Kandiah Journal of Alzheimer's Disease.2021; 82(1): 411. CrossRef
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders Qian Chen, Ting Cao, NaNa Li, Cuirong Zeng, Shuangyang Zhang, Xiangxin Wu, Bikui Zhang, Hualin Cai Frontiers in Pharmacology.2021;[Epub] CrossRef
The Association between the Binding Processes of Working Memory and Vascular Risk Profile in Adults Eirini Bika, Despina Moraitou, Elvira Masoura, George Kolios, Georgia Papantoniou, Maria Sofologi, Vasileios Papaliagkas, Georgios Ntritsos Brain Sciences.2021; 11(9): 1140. CrossRef
The effect of cordycepin on brain oxidative stress and protein expression in streptozotocin-induced diabetic mice Krittika SRISUKSAI, Kongphop PARUNYAKUL, Narumon PHAONAKROP, Sittiruk ROYTAKUL, Wirasak FUNGFUANG Journal of Veterinary Medical Science.2021; 83(9): 1425. CrossRef
The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis Jianbo Yu, Xufeng Liao, Yanzi Zhong, Yongqiang Wu, Xinsheng Lai, Huifeng Jiao, Min Yan, Yu Zhang, Chaolin Ma, Shunqi Wang Frontiers in Endocrinology.2021;[Epub] CrossRef
Impact of diabetes on the accuracy and speed of accessing information from episodic and working memory Selene Cansino, Frine Torres-Trejo, Cinthya Estrada-Manilla, Eira Castellanos-Domínguez, Ana Zamora-Olivares, Silvia Ruiz Velasco, Jim Grange Cogent Psychology.2021;[Epub] CrossRef
Ингибиторы натрий-глюкозного котранспортера способны положительно влиять на состояние головного мозга Олег Леонидович Колесников , Алла Алексеевна Колесникова , Юлия Олеговна Тарабрина Естественные и Технические Науки.2021; (№11): 149. CrossRef
Melatonin: new insights on its therapeutic properties in diabetic complications Mohammad Hossein Pourhanifeh, Azam Hosseinzadeh, Ehsan Dehdashtian, Karim Hemati, Saeed Mehrzadi Diabetology & Metabolic Syndrome.2020;[Epub] CrossRef
Diabetic encephalopathy causes the imbalance of neural activities between hippocampal glutamatergic neurons and GABAergic neurons in mice Chun Wang, Juan Li, Shidi Zhao, Li Huang Brain Research.2020; 1742: 146863. CrossRef
Link between Diabetes and Alzheimer’s Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages Gabriela Dumitrita Stanciu, Veronica Bild, Daniela Carmen Ababei, Razvan Nicolae Rusu, Alina Cobzaru, Luminita Paduraru, Delia Bulea Journal of Clinical Medicine.2020; 9(6): 1713. CrossRef
Background Brain volume is associated with dementia and depression in the elderly. An easy way to predict relative brain volume is to measure head circumference. In this study, we investigated the relationship between head circumference and cognition as well as depression in a non-demented elderly community.
Methods Baseline and follow-up surveys were conducted in 2007 and 2010. At baseline, community residents aged 65 years or over (n=382) within a rural area of South Korea were screened for dementia and symptoms of depression and were followed using the same screening battery after 3 years (n=279). Data from anthropometric measurements (head circumference, height, and body weight), demographics, and blood tests were gathered. Neuropsychological tests, including the Korean version of mini-mental state examination (K-MMSE), clinical dementia rating (CDR) including the CDR-sum of boxes, the Korean version of instrumental activities of daily living, and geriatric depression scale (GDS), were performed. None of the 279 subjects followed were demented.
Results Baseline performance on the K-MMSE and GDS was poorer for participants with smaller head circumferences. Follow-up performance on the MMSE was also poorer for participants with smaller head circumferences. Interestingly, participants with smaller head circumference showed worse GDS scores at baseline but on follow-up examination, participants with larger head circumference showed rapid worsening than those with smaller head circumference with marginal significance by ANOVA test. In regression coefficient analysis, GDS decline showed significant difference.
Conclusion Head circumference was not associated with cognitive change but was associated with symptoms of depression in non-demented community residents.
PURPOSE: The purpose of this study was to find out cognitive function of the patients with subjective memory complaint. MATERIAL AND METHODS: From March 1st 2005 to May 31st 2009, 155 normal individuals without any medical illness who visited Yeungnam University Hospital to undergo medical checkup with neurocognitive test was enrolled, and checked by using Cognitive Assessment & Reference Diagnostic System. RESULTS: 107 of the patients had normal cognitive function, 21 patients (about 15%) were diagnosed with dementia, and 10 patients (about 7%) were diagnosed with considerable psychiatric illness, such as depression, anxiety disorder, adjustment disorder. CONCLUSION: Because the patients with subjective memory complaint can be diagnosed as any psychiatric illness as well as dementia, sensitive screening test and early psychiatric approach is needed.
Citations
Citations to this article as recorded by
Effects of a Cognition Activation Program for the Institutionalized Old-Old in Korea Hung Sa Lee, Dohyun Lee Journal of Korean Academy of Community Health Nursing.2013; 24(4): 427. CrossRef
Dementia in the Parkinson’s disease has been increasingly recognized especially in old age. And akinetic-rigid symptoms or cognitive impairment at onset of Parkinson’s disease (PD) are also high risk factors for dementia. However, there have been no gold standard guideline in order to identify the Parkinson’s disease dementia (PDD). Recently, the Movement Disorder Society developed a new diagnostic criteria for PDD in December 2007. I introduce a new PDD diagnostic criteria proposal with a review of treatment strategy of PDD. After the sensitivity and specificity of these criteria ascertained, a revision may be need. But they promising clinical and prospective research baselines in the future.
PURPOSE: This study was conducted to assess the level of agreement among survey instruments used to study dementia and to determine the prevalence rate of suspected dementia using different instruments. SUBJECTS AND METHODS: A total 171 subjects older than 65 in Gyeongju-si, Gyeongsangbuk-do, were surveyed from February to October 2003. The age, sex and educational level were examined through interview surveys, and cognitive function was evaluated using three survey instruments including MMSE-K, S-SDQ, and KDSQ. RESULTS: The cognitive function scores obtained with the MMSE-K showed significant difference according to age. For sex and educational level significant differences were observed with all three survey instruments. The kappa index, the level of agreement between the questionnaires, was 0.302 between MMSE-K and S-SDQ, 0.401 between MMSE-K and KDSQ, and 0.762 between KDSQ and S-SDQ. The prevalence rate of suspected dementia based on the criteria suggested by MMSE-K, S-SDQ, and KDSQ was 27.5%, 15.2%, and 17.0% respectively. CONCLUSION: The results of this study suggest that caution is needed when comparing the measured cognitive function scores and analyzing the prevalence of dementia; this is because the prevalence of dementia and cognitive functions vary according to the questionnaires used.